[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71 (3):209-249.
[2]RASKOV H,SOBY JH,TROELSEN J,et al.Driver gene mutations and epigenetics in colorectal cancer[J].Ann Surg,2020,271 (1):75-85.
[3]DEKKER E,TANIS PJ,VLEUGELS JLA,et al.Colorectal cancer[J].Lancet,2019,394(10207):1467-1480.
[4]HUANG M,SHEN A,DING J,et al.Molecularly targeted cancer therapy:some lessons from the past decade[J].Trends Pharmacol Sci,2014,35(1):41-50.
[5]YANG Z,JIANG S,SHANG J,et al.LncRNA:Shedding light on mechanisms and opportunities in fibrosis and aging[J].Ageing Res Rev,2019,52:17-31.
[6]LIM LJ,WONG SYS,HUANG F,et al.Roles and regulation of long noncoding RNAs in hepatocellular carcinoma[J].Cancer Res,2019,79(20):5131-5139.
[7]CHEN L,HE M,ZHANG M,et al.The role of non-coding RNAs in colorectal cancer,with a focus on its autophagy[J].Pharmacol Ther,2021,226:107868.
[8]WEI L,WANG X,LV L,et al.The emerging role of noncoding RNAs in colorectal cancer chemoresistance[J].Cell Oncol (Dordr),2019,42(6):757-768.
[9]潘雪峰,范乃军,高春芳.LncRNA与结直肠癌诊断治疗的研究进展[J].肿瘤学杂志,2017,23(2):111-115.
PAN XF,FAN NJ,GAO CF.Progress on long non-coding RNA in diagnosis and treatment of colorectal cancer[J].Journal of Chinese Oncology,2017,23(2):111-115.
[10]WANG FW,CAO CH,HAN K,et al.APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production[J].J Clin Invest,2019,129(2):727-743.
[11]LAN Y,XIAO X,HE Z,et al.Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer[J].Nucleic Acids Res,2018,46(11):5809-5821.
[12]XING L,ZHANG X,CHEN A.Prognostic 4-lncRNA-based risk model predicts survival time of patients with head and neck squamous cell carcinoma[J].Oncol Lett,2019,18(3):3304-3316.
[13]LUANG T,ZHANG TY,LV ZH,et al.The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway[J].FEBS Open Bio,2021,11(5):1504-1515.
[14]DEKKER E,REX DK.Advances in CRC prevention:screening and surveillance[J].Gastroenterology,2018,154(7):1970-1984.
[15]徐攀攀,梁晶,杨怡萍.全程新辅助治疗在直肠癌治疗中的意义[J].现代肿瘤医学,2021,29(14):2555-2559.
XU PP,LIANG J,YANG YP.Significance of total neoadjuvant therapy for local advanced rectal cancer[J].Modern Oncology,2021,29(14):2555-2559.
[16]KIM T,CROCE CM.Long noncoding RNAs:Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis[J].Cancer Lett,2018,417:89-95.
[17]WANG Y,LU JH,WU QN,et al.LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer[J].Mol Cancer,2019,18(1):174.
[18]XU J,SHAO T,SONG M,et al.MIR22HG acts as a tumor suppressor via TGFbeta/SMAD signaling and facilitates immunotherapy in colorectal cancer[J].Mol Cancer,2020,19(1):51.
[19]潘雪峰,朱小闪,蔡丰波,等.LncRNA PVT1在结直肠癌中的表达及其临床意义[J].现代肿瘤医学,2021,29(02):271-275.
PAN XF,ZHU XS,CAI FB,et al.The expression and its significance of LncRNA PVT1 in colorectal cancer[J].Modern Oncology,2021,29(02):271-275.
[20]WANG L,SUN L,LIU R,et al.Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1alpha signaling loop promotes hepatocellular carcinoma progression[J].J Exp Clin Cancer Res,2021,40(1):72.
[21]WU Y,YANG X,CHEN Z,et al.m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1[J].Mol Cancer,2019,18(1):87.